Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Bupivacaine for Post-Cesarean Pain
NCT03383588Phase 2Terminated
- Sponsor
- Montefiore Medical Center
- Start
- Jul 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms), sponsored by Montefiore Medical Center. Primary endpoint: Amount of Supplemental Oxycodone Used. Started Jul 2018; status: terminated.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03383588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03383588.